Commercial Lead, Australia

Iovance Biotherapeutics is seeking a Commercial Lead for Australia to spearhead the commercialization and scaling of their tumor-infiltrating lymphocyte (TIL) therapies, including AMTAGVI (lifileucel) and Proleukin. This senior role involves developing and executing the Australian commercial strategy, overseeing profit-and-loss performance, and ensuring the successful launch and growth of these therapies in the Australian market. The position reports directly to the Senior Vice President of Global Access, Operations, and Proleukin.